Enter your login e-mail to the account
Search
Search parameters
Search results
- Treatment of urothelial carcinoma bladder cancer
MUDr. Jana Katolická, Ph.D., MUDr. Lucia Tomková
(3/2023, Review articles ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology )
- Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - The role of immuotherapy in the treatment of colorectal cancer
MUDr. Branislav Bystrický, PhD., MPH
(1/2022, Main topic ) - Pembrolizumab versus Chemotherapy for PD-L1–Positive Non-Small-Cell Lung Cancer
doc. MUDr. Peter Beržinec, CSc.
(5/2016, Information & comments ) - Enfortumab vedotin in advanced urothelial carcinoma treatment
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(5/2021, Drugs & drug classes ) - Úvodné slovo
MUDr. Iveta Andrezálová Vochyanová
(6/2016, Editorial ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - News in the immunotherapy of nonmetastatic non-small-cell lung cancer
MUDr. Lenka Medvecová
(1/2023, Main topic ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - New trends in the immunotherapy of cancer
MUDr. Ján Lakota, CSc.
(6/2016, Review articles ) - The role of immunotherapy in the treatment of unresectable and metastatic malignant melanoma
MUDr. Silvia Jurišová, PhD.
(1/2023, Main topic ) - Immune Checkpoint Blockade in Cancer Therapy
doc. MUDr. Peter Beržinec, CSc.
(3/2015, Information & comments ) - Immunotherapy in advanced urothelial carcinomas
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(1/2023, Main topic ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - Treatment of pulmonary neuroendocrine tumors
MUDr. Milan Krošlák
(5/2017, Main topic ) - New recommendations for adjuvant and first-line treatment of metastatic clear cell renal carcinoma
MUDr. Milan Krošlák
(4/2022, Main topic ) - Immunotherapy in prostate cancer
MUDr. Katarína Rejleková, PhD.
(5/2020, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Data back Merck’s Keytruda for first-line NSCLC
doc. MUDr. Peter Beržinec, CSc.
(3/2016, Information & comments ) - Diagnosis and treatment of malignant mesothelioma
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2019, Main topic ) - The turbulent evolution of treatment strategies for early-diagnosed NSCLC
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(S2/2023, Review articles ) - Systemic treatment of recurrent and/or metastatic head and neck carcinoma
MUDr. Lucia Fedorková, MUDr. Klaudia Gočárová, PhD., doc. RNDr. Martina Ondrušová, PhD., MPH, prof. MUDr. Dalibor Ondruš, DrSc.
(3/2021, Main topic ) - Current possibilities of immunotherapy in non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(3/2020, Review articles ) - Advanced urothelial carcinoma systemic treatment in the light of immunotherapy
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA
(3/2017, Review articles ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Pembrolizumab Approved by the FDA for Microsatellite Instability-High and Mismatch Repair Deficient Cancers
Doc. MUDr. Peter Beržinec, CSc.
(3/2017, Information & comments ) - Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm
MUDr. Lucia Denková, MUDr. František Sándor, PhD., FCCP
(3/2018, Main topic ) - Zriedkavé nádory gastrointestinálneho systému s akcentom na análny karcinóm
MUDr. Tomáš Šálek
(3/2018, Main topic ) - Adjuvant treatment of stage III melanoma after complete resection
MUDr. Silvia Jurišová, PhD.
(2/2022, Review articles ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - Current possibilities of immunotherapy in the treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(4/2016, Main topic ) - Immune therapy of metastatic renal cell carcinoma
MUDr. Michal Chovanec, PhD.
(4/2016, Main topic ) - Hodgkin lymphoma in children and adolescents – optimization of treatment
doc. MUDr. Alexandra Kolenová, PhD., MUDr. Andrea Hrašková
(1/2016, Main topic ) - Malignant melanoma in children and adolescents
MUDr. Viera Bajčiová, CSc.
(1/2016, Main topic ) - Pembrolizumab for the treatment of non-small-cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(2/2015, Information & comments ) - 17. svetová konferencia o karcinóme pľúc
Doc. MUDr. Peter Beržinec, CSc.
(1/2017, Events ) - Initial treatment of metastatic renal cell carcinoma
MUDr. Jana Obertová, PhD.
(1/2018, Main topic ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic ) - Treatment metastatic gastric cancer
MUDr. Vanda Ušáková, PhD.
(1/2018, Review articles ) - Niektoré nové poznatky zo sympózia ASCO GI San Francisco 2018
MUDr. Tomáš Šálek
(1/2018, Events ) - Správa z XXI. košických chemoterapeutických dní
MUDr. Jana Jankurová
(1/2018, Events ) - Metastatic Merkel cell carcinoma and its treatment options
MUDr. Michaela Sojáková
(3/2023, Review articles )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Novinky v dermatoonkológii
(1/2018, Information & comments ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year )